Medical Condition News

RSS

Treating obstructive sleep apnea in stroke patients improves recovery from stroke

A new study shows that patients in stroke rehabilitation treated for their co-existing obstructive sleep apnea (OSA) recovered better from stroke than those whose OSA was not treated.

6 Apr 2011

More than 900 young Britons diagnosed with the deadliest form of skin cancer each year

Each day more than two people under 35 in Britain are diagnosed with malignant melanoma - the deadliest form of skin cancer - according to new figures from Cancer Research UK.

6 Apr 2011

Neurocrine completes NBI-98854 Phase IIa study in schizophrenia patients with dyskinesia

Neurocrine Biosciences, Inc. announced today that it has completed the dosing and preliminary assessment of the initial cohort of Tardive Dyskinesia patients using its proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.

6 Apr 2011

Caliper's CDAS unit enters cancer research collaboration with Denver-based CHI

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life-sciences research, today announced that its Caliper Discovery Alliances and Services unit has formed a research collaboration with Denver-based Catholic Health Initiatives, one of the nation's largest health systems.

6 Apr 2011

TomTec, GE partner to deliver enhanced cardiology patient care

GE Healthcare IT, a global leader in healthcare information technology, and TomTec Imaging Systems, a proven leader in cardiovascular ultrasound analysis, are working together to deliver enhanced patient care.

6 Apr 2011

Sleep apnea people may face risk of suffering ischemic stroke

According to research presented at the School of Medicine and the University of Navarra Hospital by Dr. Roberto Muñoz, a physician of the Neurology Service of the Hospital Complex of Navarra, those persons with serious cases of sleep apnea have more than twice the possibility of suffering an ischemic stroke. Specifically, 2.5 times more.

6 Apr 2011

Genzyme, Isis present mipomersen phase 3 study data in severe heFH at ACC meeting

Genzyme Corp., a subsidiary of sanofi-aventis Group, and Isis Pharmaceuticals Inc. announced today that data from two phase 3 studies of mipomersen in patients who had high cholesterol levels while on lipid-lowering therapy were presented at the American College of Cardiology's 60th Annual Scientific Session.

6 Apr 2011

Titan Spine's Endoskeleton lumbar interbody fusion devices receive European CE Mark Certification

Titan Spine, a medical device surface technology company focused on the development of innovative spinal interbody fusion implants, announced today that it has received CE Mark Certification to commercially release its line of Endoskeleton® lumbar interbody fusion devices in Europe.

5 Apr 2011

MR patients treated with Abbott MitraClip system demonstrate clinical benefits of initial treatment at two years

Abbott today announced data from its EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) study showing that patients with significant mitral regurgitation (MR) treated with the company's investigational percutaneous catheter-based MitraClip® system continue to demonstrate the clinical benefits of initial treatment shown at one year out to two years, including improvements in heart function and reductions in symptoms.

5 Apr 2011

New risk calculator predicts risk of postoperative complications for bariatric surgery patients

A new risk calculator can predict the risk of postoperative complications occurring for individual bariatric surgery patients, according to a study published in the March issue of the Journal of the American College of Surgeons. The risk calculator will help in surgical decision-making and will help patients better understand what they can expect during recovery in order to prepare for a bariatric operation.

5 Apr 2011

Single-incision gall bladder surgery as safe and effective as standard multi-port cholecystectomy

Covidien, a leading global provider of healthcare products, today announced interim results of its multicenter, international, prospective SILS™ Port laparoscopic cholecystectomy (removal of the gall bladder) post-market clinical study.

5 Apr 2011

ARIAD's ponatinib potently inhibits all four FGFRs abnormally expressed in multiple cancers

ARIAD Pharmaceuticals, Inc. today announced results of preclinical studies on ponatinib, its investigational pan-BCR-ABL inhibitor, showing potent inhibition of all four members of the fibroblast growth factor receptor (FGFR) family of tyrosine kinases that are abnormally expressed in multiple cancers. ARIAD scientists are presenting the data this morning at the American Association for Cancer Research (AACR) Annual Meeting in Orlando, Florida.

5 Apr 2011

Insurance payers extend coverage for PTNS using Uroplasty's Urgent PC Neuromodulation System for OAB

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that two private insurance payers have elected to cover posterior tibial nerve stimulation (PTNS) using its Urgent PC Neuromodulation System for the treatment of overactive bladder (OAB) and associated symptoms.

5 Apr 2011

Certified asthma and allergy friendly bedding in hotel rooms

Whether traveling for business or pleasure, the growing population of people with asthma and allergies now has a luxury hotel option that features Certified asthma & allergy friendly® bedding in every room when visiting the Boston area. The Lenox Hotel in the historic Back Bay now features all natural SmartSilk™ silk-filled bedding that has been certified by the Asthma and Allergy Foundation of America (AAFA).

5 Apr 2011

RE-LY trial results suggest Pradaxa capsule reduces risk of stroke in AF patients

Two new retrospective subanalyses of the RE-LY trial, involving Pradaxa capsules, suggested that the reduction in stroke risk achieved with PRADAXA 150mg over warfarin occurred irrespective of CHA2DS2-VASc risk score and the type of non-valvular atrial fibrillation.

5 Apr 2011

NIPH study finds NDMA as one of the most carcinogenic compounds formed during CO2 capture

CO2 capture by means of amines is considered to be the most appropriate method to quickly begin with CO2 removal. During this capture process, some of the amines escaping the recycling process will be emitted into the air and will also form other compounds such as nitrosamines and nitramines.

5 Apr 2011

Plackers launches new dental online club for kids

Plackers, a leading brand of consumer oral care products and makers of the first disposable dental flosser, is launching Plackers Kids, its new kid-friendly dental flossers; the Plackers Kids Club, an online club for kids featuring free interactive games and activities that encourage healthy dental hygiene habits; and the Plackers Kids Club Sweepstakes, offering families the chance to win a trip for four to the popular theme park destination, Orlando, Fla. among other prizes.

5 Apr 2011

Ubiquitine D gene may be linked to celiac disease

Celiac disease (CD) involves intolerance to gluten and, consequently, suffering chronic illness in the small intestine. It is a genetic disorder, the immunological indications of which can be traced in the human body prior to the everyday activities of future sufferers being affected. For example, persons with genetic antecedents for CD develop antibodies against the gene tTG (the enzyme known as tissue transglutaminase), even before the illness becomes active, due to a cell reaction against gluten.

5 Apr 2011

Toshiba highlights new enhancements for cardiac ultrasound imaging at ACC meeting

Ultrasound is often used as a first-line diagnostic exam to quickly and safely diagnose a range of patient conditions. At this year's American College of Cardiology annual meeting in New Orleans, April 2 - 5, 2011, Toshiba America Medical Systems, Inc., will highlight new enhancements to its cardiac and shared service ultrasound systems that are designed to enhance cardiac ultrasound imaging.

5 Apr 2011

Siemens Hearing to unveil new instruments at AudiologyNOW! 2011

Siemens Hearing Instruments, Inc., will unveil a host of products at the American Academy of Audiology AudiologyNOW! 2011 conference - including the new Aquaris™, the world's first, truly waterproof, dustproof and shock-resistant digital hearing instrument.

5 Apr 2011

Medical Condition News

Treating obstructive sleep apnea in stroke patients improves recovery from stroke

More than 900 young Britons diagnosed with the deadliest form of skin cancer each year

Neurocrine completes NBI-98854 Phase IIa study in schizophrenia patients with dyskinesia

Caliper's CDAS unit enters cancer research collaboration with Denver-based CHI

TomTec, GE partner to deliver enhanced cardiology patient care

Sleep apnea people may face risk of suffering ischemic stroke

Genzyme, Isis present mipomersen phase 3 study data in severe heFH at ACC meeting

Titan Spine's Endoskeleton lumbar interbody fusion devices receive European CE Mark Certification

MR patients treated with Abbott MitraClip system demonstrate clinical benefits of initial treatment at two years

New risk calculator predicts risk of postoperative complications for bariatric surgery patients

Single-incision gall bladder surgery as safe and effective as standard multi-port cholecystectomy

ARIAD's ponatinib potently inhibits all four FGFRs abnormally expressed in multiple cancers

Insurance payers extend coverage for PTNS using Uroplasty's Urgent PC Neuromodulation System for OAB

Certified asthma and allergy friendly bedding in hotel rooms

RE-LY trial results suggest Pradaxa capsule reduces risk of stroke in AF patients

NIPH study finds NDMA as one of the most carcinogenic compounds formed during CO2 capture

Plackers launches new dental online club for kids

Ubiquitine D gene may be linked to celiac disease

Toshiba highlights new enhancements for cardiac ultrasound imaging at ACC meeting

Siemens Hearing to unveil new instruments at AudiologyNOW! 2011

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News